Biological Aging Associates With Preeclampsia and Gestational Hypertension

BACKGROUND: Biological aging is a fundamental driver of chronic disease, yet its role in the cause of preeclampsia and gestational hypertension remains poorly defined. METHODS: We used a multimodal framework that triangulated genetic, epidemiological, and experimental approaches to assess the associations of biological aging with preeclampsia and gestational hypertension. Publicly available human and mouse transcriptomic data were analyzed to identify shared aging- and preeclampsia-associated signatures, while the potential of nicotinic acid to alleviate aging- and preeclampsia-related features was further evaluated in experimental models. RESULTS: Two-sample Mendelian randomization demonstrated that biological age acceleration was associated with higher odds of preeclampsia (odds ratio, 1.55 [95% CI, 1.22–1.96]; P =2.67×10 − 4 ) and gestational hypertension (odds ratio, 1.56 [95% CI, 1.12–2.19]; P =0.009), while positive genetic correlations were also observed for both outcomes. In the nested case-control study, higher early pregnancy biological age acceleration was consistently associated with preeclampsia risk in both primary (odds ratio, 1.16 [95% CI, 1.01–1.35]; P =0.047) and sensitivity (odds ratio, 1.14 [95% CI, 1.03–1.29]; P =0.042) analyses, with the associations persisting after covariate adjustment and exclusion of systolic blood pressure from biological age acceleration calculation. Mouse models exhibited preeclampsia-like features accompanied by concordant alterations in biological age-related biomarkers and telomere dysfunction. These changes were partially attenuated by nicotinic acid treatment, whereas placental organoids showed limited growth responses to nicotinic acid. Complementing these phenotypic observations, transcriptomic analyses identified shared aging- and preeclampsia-associated signatures across human and mouse data sets. CONCLUSIONS: Convergent evidence links biological aging with preeclampsia and gestational hypertension, particularly biological age acceleration with preeclampsia. Experimental findings provide complementary context but do not establish a specific mechanism or therapeutic role for nicotinic acid.

Authors

Institutions

Publication Details

Journal
Hypertension
Published
2026-11-18
DOI
https://doi.org/10.1161/hypertensionaha.126.28011
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biological Aging Associates With Preeclampsia and Gestational Hypertension

Tang Shuhua, Cairong Zhu, Yidie Lin, Xiong‐Fei Pan et al.
2 links
Hypertension
Pregnancy and preeclampsia studies
article

Biological Aging Associates With Preeclampsia and Gestational Hypertension

Tang Shuhua, Cairong Zhu, Yidie Lin, Xiong‐Fei Pan, Jian Zhao, Jianfeng He, Huanqiang Zhao, Yuqian Mo, Xuechao Li
article en

Abstract

BACKGROUND: Biological aging is a fundamental driver of chronic disease, yet its role in the cause of preeclampsia and gestational hypertension remains poorly defined. METHODS: We used a multimodal framework that triangulated genetic, epidemiological, and experimental approaches to assess the associations of biological aging with preeclampsia and gestational hypertension. Publicly available human and mouse transcriptomic data were analyzed to identify shared aging- and preeclampsia-associated signatures, while the potential of nicotinic acid to alleviate aging- and preeclampsia-related features was further evaluated in experimental models. RESULTS: Two-sample Mendelian randomization demonstrated that biological age acceleration was associated with higher odds of preeclampsia (odds ratio, 1.55 [95% CI, 1.22–1.96]; P =2.67×10 − 4 ) and gestational hypertension (odds ratio, 1.56 [95% CI, 1.12–2.19]; P =0.009), while positive genetic correlations were also observed for both outcomes. In the nested case-control study, higher early pregnancy biological age acceleration was consistently associated with preeclampsia risk in both primary (odds ratio, 1.16 [95% CI, 1.01–1.35]; P =0.047) and sensitivity (odds ratio, 1.14 [95% CI, 1.03–1.29]; P =0.042) analyses, with the associations persisting after covariate adjustment and exclusion of systolic blood pressure from biological age acceleration calculation. Mouse models exhibited preeclampsia-like features accompanied by concordant alterations in biological age-related biomarkers and telomere dysfunction. These changes were partially attenuated by nicotinic acid treatment, whereas placental organoids showed limited growth responses to nicotinic acid. Complementing these phenotypic observations, transcriptomic analyses identified shared aging- and preeclampsia-associated signatures across human and mouse data sets. CONCLUSIONS: Convergent evidence links biological aging with preeclampsia and gestational hypertension, particularly biological age acceleration with preeclampsia. Experimental findings provide complementary context but do not establish a specific mechanism or therapeutic role for nicotinic acid.

Hypertension
Sichuan University (CN), West China Medical Center of Sichuan University (CN), Southern University of Science and Technology (CN), West China Second University Hospital of Sichuan University (CN), West China Hospital of Sichuan University (CN), Shenzhen Maternity and Child Healthcare Hospital (CN), Southern Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon